CCL16 and cancer: Another recent study has shown that CCL16 binds explicitly to CCR2, which in turn activates the AKT/mitogenic effector kinase (GSK3β) signaling and promotes β-catenin nuclear translocation, leading to enhanced cancer cell stemness (50) (Figure 1D).